Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study

✍ Scribed by Calabresi, Peter A; Kieseier, Bernd C; Arnold, Douglas L; Balcer, Laura J; Boyko, Alexey; Pelletier, Jean; Liu, Shifang; Zhu, Ying; Seddighzadeh, Ali; Hung, Serena; Deykin, Aaron

• Book ID: 121843270
• Publisher: The Lancet
• Year: 2014
• Tongue: English
• Weight: 290 KB
• Volume: 13
• Category: Article
• ISSN: 1474-4465
• DOI: 10.1016/S1474-4422(14)70068-7